| 101 |
18373616 | Diabetes, colorectal cancer and cyclooxygenase 2 inhibition. | 2008 May |
1 |
| 102 |
18393288 | Acetylsalicylic acid inhibits hepatitis C virus RNA and protein expression through cyclooxygenase 2 signaling pathways. | 2008 May |
5 |
| 103 |
18483385 | Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels. | 2008 May 15 |
1 |
| 104 |
18636671 | Mechanisms underlying aspirin-mediated growth inhibition and apoptosis induction of cyclooxygenase-2 negative colon cancer cell line SW480. | 2008 Jul 14 |
1 |
| 105 |
18660649 | Pharmacology of cyclooxygenase-2 inhibitors and preemptive analgesia in acute pain management. | 2008 Aug |
1 |
| 106 |
18702823 | Similar reductions in the risk of human colon cancer by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors. | 2008 Aug 14 |
2 |
| 107 |
17242290 | Letter by Kronish et al regarding article, "Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance". | 2007 Jan 23 |
1 |
| 108 |
17301265 | Blood levels of long-chain polyunsaturated fatty acids, aspirin, and the risk of colorectal cancer. | 2007 Feb |
1 |
| 109 |
17329938 | Screening method for nonsteroidal antiinflammatory drugs based on the cyclooxygenase 2 pathway activated by serum-free stimulation in A549 cells. | 2007 Mar |
2 |
| 110 |
17488476 | Pathogenesis of colorectal carcinoma and therapeutic implications: the roles of the ubiquitin-proteasome system and Cox-2. | 2007 Mar-Apr |
1 |
| 111 |
17522398 | Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. | 2007 May 24 |
7 |
| 112 |
17589567 | Reduced risk of human lung cancer by selective cyclooxygenase 2 (COX-2) blockade: results of a case control study. | 2007 Jun 13 |
1 |
| 113 |
17611980 | The effect of low-dose aspirin on the decreased risk of development of dyspepsia and gastrointestinal ulcers associated to cyclooxygenase-2 selective inhibitors. | 2007 Aug |
5 |
| 114 |
17640058 | Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial. | 2007 Nov 1 |
1 |
| 115 |
17663920 | Safety of celecoxib in patients with cutaneous reactions due to ASA-NSAIDs intolerance. | 2007 Jul-Aug |
1 |
| 116 |
17892525 | Hospitalization for gastrointestinal adverse events attributable to the use of low-dose aspirin among patients 50 years or older also using non-steroidal anti-inflammatory drugs: a retrospective cohort study. | 2007 Nov 15 |
1 |
| 117 |
17978563 | Copper-aspirin complex inhibits cyclooxygenase-2 more selectively than aspirin. | 2007 Nov |
1 |
| 118 |
18167181 | Aspirin inhibits the proliferation of tobacco-related esophageal squamous carcinomas cell lines through cyclooxygenase 2 pathway. | 2007 Dec 5 |
3 |
| 119 |
16175430 | The renal effects of the addition of low-dose aspirin to COX-2 selective and nonselective antiinflammatory drugs. | 2006 Feb |
1 |
| 120 |
16480405 | Primary care physician perceptions of non-steroidal anti-inflammatory drug and aspirin-associated toxicity: results of a national survey. | 2006 Mar 1 |
2 |
| 121 |
16493264 | Aspirin and NSAIDs: effects in breast and ovarian cancers. | 2006 Feb |
1 |
| 122 |
16529823 | Ascorbic acid enhances the inhibitory effect of aspirin on neuronal cyclooxygenase-2-mediated prostaglandin E2 production. | 2006 May |
5 |
| 123 |
16613568 | Lipoxin and synthetic lipoxin analogs: an overview of anti-inflammatory functions and new concepts in immunomodulation. | 2006 Apr |
2 |
| 124 |
16630404 | Association between nonsteroidal anti-inflammatory drugs and prostate cancer occurrence. | 2006 Mar-Apr |
1 |
| 125 |
16785341 | Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance. | 2006 Jun 27 |
1 |
| 126 |
16792983 | [Cyclooxygenase-2: a new therapeutic target in atherosclerosis?]. | 2006 May 27 |
1 |
| 127 |
16951898 | New perspectives on aspirin and the endogenous control of acute inflammatory resolution. | 2006 Aug 31 |
2 |
| 128 |
17037745 | [Effects of nonsteroidal anti-inflammatory drug celecoxib on expression of cyclooxygenase-2 (COX-2) in ovarian carcinoma cell]. | 2006 Sep |
2 |
| 129 |
15345481 | Distinct cAMP signaling pathways differentially regulate alpha2C-adrenoceptor expression: role in serum induction in human arteriolar smooth muscle cells. | 2005 Jan |
1 |
| 130 |
15681294 | Transcriptional Control of COX-2 via C/EBPbeta. | 2005 Apr |
1 |
| 131 |
15741988 | Modulation of COX-2 expression in peripheral blood cells by increased intake of fruit and vegetables? | 2005 Apr |
1 |
| 132 |
15756426 | Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review). | 2005 Apr |
1 |
| 133 |
15763541 | Dual effects of acetylsalicylic acid on mast cell degranulation, expression of cyclooxygenase-2 and release of pro-inflammatory cytokines. | 2005 Apr 1 |
3 |
| 134 |
15767339 | PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs. | 2005 Mar |
2 |
| 135 |
15811890 | Prospective study of acute gastrointestinal bleeding attributable to anti-inflammatory drug ingestion in the Yorkshire region of the United Kingdom. | 2005 Apr |
1 |
| 136 |
15811906 | Angioedema associated with aspirin and rofecoxib. | 2005 May |
5 |
| 137 |
15955733 | Aspirin and steroids: new mechanistic findings and avenues for drug discovery. | 2005 Aug |
1 |
| 138 |
16101563 | Monocyte cyclooxygenase-2 activity: a new therapeutic target for atherosclerosis? | 2005 Aug |
1 |
| 139 |
16136765 | Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema. | 2005 Aug |
2 |
| 140 |
16137190 | Pathogenesis and management of aspirin-intolerant asthma. | 2005 |
1 |
| 141 |
16336399 | Aspirin induces apoptosis in oesophageal cancer cells by inhibiting the pathway of NF-kappaB downstream regulation of cyclooxygenase-2. | 2005 Nov |
1 |
| 142 |
16371720 | [Characteristics of colon cancer diagnosed in patients taking aspirin or warfarin]. | 2005 Dec |
1 |
| 143 |
14722849 | Colon polyps and cancer. | 2004 Jan |
1 |
| 144 |
15043523 | COX-2-selective inhibitors and the risk of upper gastrointestinal bleeding in high-risk patients with previous gastrointestinal diseases: a population-based case-control study. | 2004 Apr 1 |
1 |
| 145 |
15056798 | Micromolar concentrations of sodium arsenite induce cyclooxygenase-2 expression and stimulate p42/44 mitogen-activated protein kinase phosphorylation in normal human epidermal keratinocytes. | 2004 Jun |
1 |
| 146 |
15120641 | Fibronectin-induced COX-2 mediates MMP-2 expression and invasiveness of rhabdomyosarcoma. | 2004 May 28 |
1 |
| 147 |
15144225 | Benzo[a]pyrene regulates osteoblast proliferation through an estrogen receptor-related cyclooxygenase-2 pathway. | 2004 May |
1 |
| 148 |
15167166 | The relationship between cyclooxygenase-2 expression and characteristics of malignant transformation in human colorectal adenomas. | 2004 Jun |
2 |
| 149 |
15213311 | Activation of phosphoinositide 3-kinase in response to high glucose leads to regulation of reactive oxygen species-related nuclear factor-kappaB activation and cyclooxygenase-2 expression in mesangial cells. | 2004 Jul |
1 |
| 150 |
15242680 | Nitric-oxide-donating NSAIDs as agents for cancer prevention. | 2004 Jul |
1 |